17-(cyclopropylmethyl)-6beta-(benzyloxy)-4,5alpha-epoxy-3,14-dihydroxymorphinan

ID: ALA2112732

PubChem CID: 71456227

Max Phase: Preclinical

Molecular Formula: C27H31NO4

Molecular Weight: 433.55

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Oc1ccc2c3c1OC1[C@H](OCc4ccccc4)CCC4(O)C(C2)N(CC2CC2)CCC314

Standard InChI:  InChI=1S/C27H31NO4/c29-20-9-8-19-14-22-27(30)11-10-21(31-16-18-4-2-1-3-5-18)25-26(27,23(19)24(20)32-25)12-13-28(22)15-17-6-7-17/h1-5,8-9,17,21-22,25,29-30H,6-7,10-16H2/t21-,22?,25?,26?,27?/m1/s1

Standard InChI Key:  LLYKFTJDMLXUDK-XVMPFKDUSA-N

Molfile:  

     RDKit          2D

 32 38  0  0  0  0  0  0  0  0999 V2000
    9.7865   -3.6649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0788   -3.2507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7923   -4.4762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5632   -3.4060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5114   -4.8904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0464   -4.0619    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3711   -3.6649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6520   -3.4751    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0788   -4.8904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3711   -4.4876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9580   -3.6591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9073   -3.2507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9271   -3.0608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4147   -3.0436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5114   -5.7189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2389   -4.0619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9271   -2.2323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3355   -1.5189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5070   -1.5247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0788   -5.7189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0016   -3.6246    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8602   -2.4509    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6207   -2.8307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7923   -6.1331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9958   -4.4531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2248   -6.1331    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7955   -4.6660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0026   -5.4600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3651   -4.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1705   -4.2863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7966   -5.6786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3834   -5.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  1  1  0
  5  3  2  0
  6  4  1  0
  7  2  1  0
  8 16  1  0
  9  3  1  0
 10  9  1  0
 11  1  1  0
 12  2  1  0
 13  8  1  0
 14  4  1  0
 15  5  1  0
 16 11  1  0
 17 13  1  0
 18 17  1  0
 19 17  1  0
 20  9  2  0
 14 21  1  1
 22  2  1  0
 23 14  1  0
 24 20  1  0
 25 21  1  0
 26 15  1  0
 27 25  1  0
 28 27  2  0
 29 27  1  0
 30 29  2  0
 31 28  1  0
 32 30  1  0
  5  6  1  0
  8  7  1  0
 23 12  1  0
 10  7  1  0
 15 24  2  0
 18 19  1  0
 32 31  2  0
M  END

Associated Targets(Human)

OPRK1 Tclin Opioid receptors; mu/kappa/delta (568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

OPRM1 Mu opioid receptor (3620 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Kappa opioid receptor (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 433.55Molecular Weight (Monoisotopic): 433.2253AlogP: 3.54#Rotatable Bonds: 5
Polar Surface Area: 62.16Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.30CX Basic pKa: 9.47CX LogP: 3.21CX LogD: 1.42
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.76Np Likeness Score: 1.35

References

1. Nelson TD, Davis RD, Nelson WL..  (1994)  Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol.,  37  (25): [PMID:7996538] [10.1021/jm00051a003]
2. Davis RD, Nelson WL..  (1995)  Isothiocyanate-substituted benzyl ether opioid receptor ligands derived from 6 beta-naltrexol.,  38  (3): [PMID:7853350] [10.1021/jm00003a020]

Source